"Ephrin-B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transmembrane domain containing ephrin that binds with high affinity to EPHB1 RECEPTOR; EPHB3 RECEPTOR; and EPHB4 RECEPTOR. Expression of ephrin-B2 occurs in a variety of adult tissues. During embryogenesis, high levels of ephrin-B2 is seen in the PROSENCEPHALON; RHOMBENCEPHALON; developing SOMITES; LIMB BUD; and bronchial arches.
| Descriptor ID |
D036388
|
| MeSH Number(s) |
D12.644.276.500.700 D12.776.467.500.700 D12.776.543.287.700 D23.529.500.700
|
| Concept/Terms |
Ephrin-B2- Ephrin-B2
- Ephrin B2
- LERK-5 Gene Product
- LERK 5 Gene Product
- Efbn2 Gene Product
- Eplg5 Gene Product
- LERK-5 Protein
- LERK 5 Protein
- Eplg5 Protein
Eph Ligand Family 2 Protein, Mammalian- Eph Ligand Family 2 Protein, Mammalian
- Htk Ligand
- Ligand, Htk
- Mammalian ELF-2
- ELF-2, Mammalian
- Mammalian ELF 2
- HTKL Protein
- ELF-2 Protein, Mammalian
- ELF 2 Protein, Mammalian
- Mammalian ELF-2 Protein
|
Below are MeSH descriptors whose meaning is more general than "Ephrin-B2".
Below are MeSH descriptors whose meaning is more specific than "Ephrin-B2".
This graph shows the total number of publications written about "Ephrin-B2" by people in this website by year, and whether "Ephrin-B2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 1 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ephrin-B2" by people in Profiles.
-
Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering. Int J Cancer. 2024 Oct 15; 155(8):1510-1523.
-
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein. Cell Rep. 2021 08 31; 36(9):109628.
-
ADAM10 Evens Out the Double-Edged Sword of Radiotherapy in Pancreatic Cancer. Cancer Res. 2021 06 15; 81(12):3158-3159.
-
Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Cell. 2020 12 10; 183(6):1536-1550.e17.
-
Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions. Sci Rep. 2020 01 16; 10(1):520.
-
A novel long non-coding RNA, Leat1, causes reduced anogenital distance and fertility in female mice. Differentiation. 2020 Mar - Apr; 112:1-6.
-
Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors. Mol Carcinog. 2017 03; 56(3):1189-1196.
-
Estrogen defines the dorsal-ventral limit of VEGF regulation to specify the location of the hemogenic endothelial niche. Dev Cell. 2014 May 27; 29(4):437-53.
-
EphB-ephrin-B2 interactions are required for thymus migration during organogenesis. Proc Natl Acad Sci U S A. 2010 Jul 27; 107(30):13414-9.
-
Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia. Blood. 2010 Mar 25; 115(12):2412-9.